Company intelligence / Profile preview

Norsvin

Hamar, Innlandet, Norwaytopigsnorsvin.us ↗

Ownership: Private
Development stage: Commercial

Overview

Norsvin develops and markets advanced swine genetics for improved productivity and sustainability. It has over 70 years of experience and leads in artificial insemination products with a focus on animal welfare and low environmental impact. The merger with Dutch Topigs created one of the world’s largest swine genetics companies active in over 50 countries. No clinical results as it does not develop drugs.

Therapeutic areas: Metabolic DisordersInfectious DiseasesOther
Modalities: Genetic selectionArtificial insemination products
Industry: Agriculture & AgTech

Partnerships

Merged entity "Topigs" from Netherlands to form "Topigs Norsvin"

Beyond the preview

Go deeper on Norsvin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norsvin.

Explore the full profile